Trimetazidine effects on oxidative damage
- Authors
- Hong, S.J.
- Issue Date
- 2013
- Keywords
- Myocardial infarction; Oxidative damage; Trimetazidine
- Citation
- Heart and Metabolism, no.60, pp.27 - 29
- Indexed
- SCOPUS
- Journal Title
- Heart and Metabolism
- Number
- 60
- Start Page
- 27
- End Page
- 29
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/133569
- ISSN
- 1566-0338
- Abstract
- Trimetazidine is an anti anginal medication and ensures the proper functioning of transmembrane ionic channels by maintaining intracellular ATP production in ischemic conditions. Trimetazidine prevents the accumulation of calcium in cardiomyocytes, adjusts cellular acidosis, and decreases production of free oxygen radicals. Trimetazidine blocks long chain 3-ketoacyl coenzyme A thiolase activity, thereby shifting ATP production more towards glucose oxidation instead of fatty acid β-oxidation during myocardial ischemia. By inhibiting fatty acid β-oxidation, fewer free radicals are formed in the cardiomyocytes with more efficient oxygen consumption and ATP production, resulting in recovery of myocardial contractile function and inhibition of malignant arrhythmias. Moreover, cardiac enzymatic activities such as phosphorylase and ATPase increased significantly in ischemic areas with trimetazidine pretreatment before myocardial ischemia. Protective effects of trimetazidine by increasing ventricular fibrillation threshold during coronary artery occlusion were consistent in animal studies. © 2013 by ISSN.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biomedical Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.